India proposes mandatory CCTV at medical stores for sales of controlled drugs
The Health Ministry is seeking comments on requiring pharmacies nationwide to install 6–8 CCTV cameras to monitor Schedule H, H1 and X drug sales. AIOCD estimates compliance could cost ₹50,000–₹1 lakh or more per store and flags rural connectivity and infrastructure hurdles.
What happened
Indian medical stores · Health Ministry proposes mandatory CCTV monitoring for Schedule H, H1 and X drug sales at medical stores nationwide. Chemists’ body
Key facts
- 6-8 CCTV cameras
- ₹50,000-₹100,000 or more estimated installation cost
What changed
Health Ministry proposes mandatory CCTV monitoring for Schedule H, H1 and X drug sales at medical stores nationwide. Chemists’ body AIOCD flags ₹50,000-₹1 lakh-plus compliance costs and rural infrastructure challenges.
Why this matters
India’s proposed CCTV mandate for controlled-drug sales could raise pharmacy capex and operating complexity, with rural stores facing the sharpest connectivity and infrastructure challenges.
What to watch
- Publication of final notification, implementation deadline, and whether camera count remains fixed at 6–8 per store.
- Definitions of covered drugs and whether all pharmacies or only outlets stocking Schedule H/H1/X products are in scope.
- Required footage retention period, live-monitoring requirements, police/regulator access rules, and data-privacy obligations.
- Availability of exemptions, subsidies, tax relief, or phased compliance for rural and small-format stores.
- State-level enforcement guidance, inspection activity, and penalties for non-compliance.